Taking a Deep Look at Psilocybin for Depression Research
By Michelle Jankian for Psychedelics Today
Psilocybin for depression is becoming a major avenue of clinical research. The Usona Institute out of Madison, Wisconsin is about to begin the largest psilocybin-depression study in the US. Part of the FDA’s drug approval protocol, this phase 2 clinical trial will test the magic mushroom compound in 80 individuals for safety and efficacy in treating major depressive disorder (MDD).
When Usona co-founder, Malynn Utzinger, MD presented at this year’s Horizons Conference, she explained that she and co-founder Bill Linton originally wanted to look at psilocybin for depression and anxiety in those with terminal cancer. But when they brought the idea to the FDA, the government organization basically said: Why limit yourselves to depression in cancer patients? And so they changed gears to research psilocybin for depression more generally.
Continue reading the original article here:
https://psychedelicstoday.com/2019/11/13/psilocybin-depression/
OLP Therapeutics, an Oakland, California startup, has released its first product line: natural, unaltered psilocybin mushroom medicines with exact, standardized quantities of active ingredients.
While there has been very promising evidence of safety and effectiveness for psychedelics after a few acute macrodoses in clinical trials, the risks and benefits of chronic microdosing still remain largely unknown.
Magic mushrooms (aka psilocybin mushrooms or psychedelic mushrooms) are in the news a lot recently. These mushrooms cause profound changes in human perception and consciousness when eaten. Here are five fascinating facts about the psychoactive molecules (aka compounds) in magic mushrooms.
Women have always played an integral role in psychedelic healing and research, even if they haven’t always been highlighted as mavericks in the field. But as the “Psychedelic Renaissance” goes mainstream, it’s time to start recognizing groundbreaking women in psychedelic science and activism.
Over the Holiday break, I've gotten a glimpse of what life will be like after drug laws change in the United States, after spending some time in Amsterdam, where buying psychedelics is as easy as buying an apple in a corner store (magic mushroom truffles are sold in shiny commercial packages at "smartshops" peppered throughout the city to tourists).
Breakthrough Therapy Designation establishes FDA’s organizational commitment to promoting an efficient development program for psilocybin in MDD.
Psilocybin for depression is becoming a major avenue of clinical research, the Usona Institute out of Madison, Wisconsin is about to begin the largest psilocybin-depression study in the US. Part of the FDA’s drug approval protocol…
For research in the United States, volunteers typically get the synthetic version of psychedelics. Does that matter?
Using psychedelics for personal growth; a step-by-step guide to how people have used psychedelics to improve their lives and spiritual outlook. LSD, Magic Mushrooms and other psychedelic compounds are being used for personal growth.